|
|
Am J Public Health. 1999 August; 89(8): 1240–1244. | PMCID: PMC1508695 |
Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality. M A Weinstock and B Gardstein Dermatoepidemiology Unit, VA Medical Center, Providence, RI 02908-4799, USA. maw@brown.edu Abstract OBJECTIVES: Patterns of mycosis fungoides incidence and associated mortality in the United States were evaluated. METHODS: Data were taken from the Surveillance, Epidemiology, and End Results cancer registry program and the National Center for Health Statistics. RESULTS: The incidence rate from 1973 through 1992 was 0.36/10(5) person-years. The age-adjusted incidence rate ratio of Blacks to Whites was 1.7; that of Asians to Whites was 0.6. There was no evidence of increasing incidence rates during the period 1983 through 1992. Mortality rates declined steadily from 1979 to 1991 and were less heterogeneous geographically than incidence rates. Mortality rate patterns with age, sex, and race were similar to the corresponding incidence patterns. CONCLUSIONS: The incidence rate of mycosis fungoides has stabilized and the mortality rate has declined. For unknown reasons, the disorder varies greatly among demographic and geographic subgroups. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. These references are in PubMed. This may not be the complete list of references from this article. - Weinstock MA, Horm JW. Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology. JAMA. 1988 Jul 1;260(1):42–46. [PubMed]
- Iscovich J, Paltiel O, Azizi E, Kuten A, Gat A, Lifzchitz-Mercer B, Zlotogorski A, Polliack A. Cutaneous lymphoma in Israel, 1985-1993: a population-based incidence study. Br J Cancer. 1998;77(1):170–173. [PubMed]
- Chuang TY, Su WP, Muller SA. Incidence of cutaneous T cell lymphoma and other rare skin cancers in a defined population. J Am Acad Dermatol. 1990 Aug;23(2 Pt 1):254–256. [PubMed]
- Greene MH, Dalager NA, Lamberg SI, Argyropoulos CE, Fraumeni JF., Jr Mycosis fungoides: epidemiologic observations. Cancer Treat Rep. 1979 Apr;63(4):597–606. [PubMed]
- Swanbeck G, Roupe G, Sandström MH. Indications of a considerable decrease in the death rate in mycosis fungoides by PUVA treatment. Acta Derm Venereol. 1994 Nov;74(6):465–466. [PubMed]
- Merlino LA, Sullivan KJ, Whitaker DC, Lynch CF. The independent pathology laboratory as a reporting source for cutaneous melanoma incidence in Iowa, 1977-1994. J Am Acad Dermatol. 1997 Oct;37(4):578–585. [PubMed]
- Karagas MR, Thomas DB, Roth GJ, Johnson LK, Weiss NS. The effects of changes in health care delivery on the reported incidence of cutaneous melanoma in western Washington State. Am J Epidemiol. 1991 Jan;133(1):58–62. [PubMed]
- Weinstock MA, Reynes JF. The changing survival of patients with mycosis fungoides: a population-based assessment of trends in the United States. Cancer. 1999 Jan 1;85(1):208–212. [PubMed]
- Weinstock MA, Reynes JF. Validation of cause-of-death certification for outpatient cancers: the contrasting cases of melanoma and mycosis fungoides. Am J Epidemiol. 1998 Dec 15;148(12):1184–1186. [PubMed]
- Wood GS, Salvekar A, Schaffer J, Crooks CF, Henghold W, Fivenson DP, Kim YH, Smoller BR. Evidence against a role for human T-cell lymphotrophic virus type I (HTLV-I) in the pathogenesis of American cutaneous T-cell lymphoma. J Invest Dermatol. 1996 Sep;107(3):301–307. [PubMed]
- Li G, Vowels BR, Benoit BM, Rook AH, Lessin SR. Failure to detect human T-lymphotropic virus type-I proviral DNA in cell lines and tissues from patients with cutaneous T-cell lymphoma. J Invest Dermatol. 1996 Sep;107(3):308–313. [PubMed]
- Weinstock MA. Epidemiology of mycosis fungoides. Semin Dermatol. 1994 Sep;13(3):154–159. [PubMed]
|
This article has been